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MANY workers have at various times suggested that the cancer-inducing
capacity of certain polycyclic hydrocarbons is connected in some way with their
ability to combine or associate with cell constituents. Miller (1951) and Miller and
Miller (1952) produced experimental evidence to show that a proportion of such a
carcinogen applied to the skin becomes firmly bound to the epidermis of the
treated area forming a protein-hydrocarbon complex from which the hydrocarbon
(or closely allied derivatives) can be extracted only after complete hydrolysis ofthe
tissue. It was suggested that the loss ofsome vital protein which results from such
combination is a necessary stage in the evolution of the new type of cell.
It has become a commonly accepted view that the cancer inducing activity of
such chemical agents must be explained in terms of a direct chemical action or
combination but there is some contrary opinion and evidence (Orr, 1954; Vernoni,
1951).
In a previous paper (Woodhouse, 1954) it was shown that certain polycyclic
hydrocarbons, inactive as skin carcinogens to mice, e.g., perylene and dibenza-
cridine, also become bound to epidermal protein. Moodie, Reid and Wallick (1954)
believe that their experiments indicate that the non-carcinogens are much more
weakly held than the carcinogenic hydrocarbons. Heidelberger and Moldenhauser
(1955) employing hydrocarbons labelled with C14, also showed that phenanthrene
and 1: 2 benzanthracene, inactive, or very weak carcinogens, are bound to a much
less extent than the powerful ones such as methylcholanthrene or 9: 10 dimethyl-
benzanthracene (D.M.B.A.). They also found, on the other hand, that 1: 2, 3: 4
dibenzanthracene, a non-carcinogen, is "extensively" bound.
Thus the observations are not at present capable ofgiving a simple explanation
of the process and further experiments are necessary to assess the significance of
such combination. This may be mainly concerned in the detoxification and
elimination of such substances and unconnected with, or in addition to any
specific interactions that are concerned with the production of neoplastic cells.
This report describes three series ofexperiments designed to obtaininformation
regarding: (1) The amount ofboundhydrocarbonproduced eitherunderconditions
which modify the response of the skin to carcinogenic hydrocarbons or under the
influence of agents which induce epidermal changes not leading to malignancy
(Experiments Series 1). (2) The persistence offree and bound hydrocarbon after a
single massive application of 9:10 dimethyl-1: 2-benzanthracene (Experiments
Series 2). (3) The binding property of another non-carcinogenic hydrocarbon-POLYCYCLIC HYDROCARBONS AND EPIDERMAL CONSTITUENTS
benztetraphene (Experiments Series 3). This compound is of interest since it is
non-toxic, does not inhibit somatic cell growth like many carcinogens, but has the
property ofstrongly inhibiting thegrowth ofgrafted tumours and some spntaneous
tumours, and has been suggested as capable ofmodifying the antigenic structure of
a specific protein complex (Green, 1954). It is highly fluorescent in organic
solvents and can be easily detected in "ultra-violet" light at a dilution of
1/10,ig./ml. or less in benzene or toluene.
EXPERIMENTAL.
(1) Reagents.
The following agents were employed in conjunction with the hydrocarbons for
the reasons given.
(a) Croton oil: This substance has been shown to be the most powerful known
co-carcinogen for mouse skin and has been extensively used in investigations on
the elicitation of skin tumours. (Berenblum and Shubik, 1947, 1949; Salaman
and Gwynn, 1951). It produces effects on mouse skin "not unlike those produced
by carcinogens" (Orr, 1938). Continued applications to the skin produce a few
tumours in mice (Salaman and Roe, 1953). It was employed (O1 crotonis Ang.
B.P.C.) 0.5 per cent solution in acetone, 0.2 ml. per application.
(b) Nitrogen mustard produces, after 3-10 days, a type of epidermal hyper-
plasia chiefly characterized by gross irregularity in size and arrangement of cells,
and a similar histological appearance in the epidermis to that produced by 9: 10
dimethylbenzanthracene (Salaman and Roe, 1953). It was used as 0*2 per cent
solution in acetone, 0.2 ml. per application.
(c) Urethane: This is described by Salaman and Roe (1953) as an effective
"initiating principle" which causes no skin changes apparent microscopically or
w macroscopically, and no tumours. It was used as 20 per cent V aqueoussolution,
0.2 ml. per application.
(d) Maleic anhydride was shown by Crabtree (]945) to have, in common with
some other unsaturated dibasic acids, the property ofinhibiting the production of
skin tumours by benzpyrene. It was used as 6 per cent aqueous solution.
(e) Cortisone has been found to inhibit the production of skin tumours by
D.M.B.A. when applied topically, concomitantly with the carcinogen. (Engelbreth-
Holm and Asboe-Hanson, 1.953) (Ghadially and Green, 1954). It has a depressant
effect on mititic activity in mouse epidermis (Green and Savigear, 1951; Bullough,
1952).
(f) The specimen of 3: 4 benztetraphene; naphtho-(2': 1', 1: 2) anthracene
(Clar, 1952, p. 207) used in Experiments Series 3 was kindly provided by Professor
H. N. Green. It was used as 0.1 per cent solution in toluene. It was not very
soluble in most organic solvents and this medium was necessary to obtain the
required concentration.
(2) Extraction and measurement of bound hydrocarbon.
The method previously described (Woodhouse, 1954) was used for preparing
the protein from the mouse skin. It is essentially that used by Miller (1951).
After thorough extraction with alcohol, which has been shown to extract the
unbound B.P. completely, 25 mg. samples of the dry protein were hydrolysed for
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2 hours with 4N alcoholic NaOH in presence of toluene and zinc dust. The solution
(referred to as the alkaline hydrolysate) was extracted several times with l0 ml.
benzene.
The benzene extracts, after separation and dehydration with sodium sulphate,
were combined and reduced to a suitable volume for fluorimetry.
The aqueous alkaline solution was neutralized with HC1, brought to a slightly
acid pH and again extracted with benzene. This portion is referred to as the
extract from the acidified hydrolysate. The estimation of the fluorescence values
of the extracted hydrocarbon from both procedures was also conducted as before
by comparing the extracts with appropriate dilute standard solutions of the
particular hydrocarbon initially applied.
(3) Application of Solutions.
All solutions were applied to the backs of the animnals from which thle hair had
been cleanly clipped, with care to avoid damage to the skin, one day prior to the
first application. When observations continued over a period the hair was again
removed as necessary to provide a clean tissue for chemical treatment.
Procedures in Experiments Series 1.
(]) Croton oil (followed by benzpyrene);
Urethane (followed by benzpyrene);
Nitrogen mustard (followed by benzpyrene).
Three applications of the preparing agent at 3 day intervals were made over
an area ofthe skin somewhat greater than that subsequently removed for chemical
treatment. The hydrocarbon solution was then applied for 6 successive days and
the skin removed after a further 2 days. It was not deemed practical to test the
effect of applications of the agents after benzpyrene treatment because this might
remove or disturb the carcinogen and lead to confusion in the quantitative inter-
pretation of the results.
(2) Urethane followed by benzpyrene;
Maleic anhydride followed by benzpyrene.
Applications were made every other day, for 6 days followed by benzpyrene
treatment and skin removed as in the other experiments of this group.
Procedures in Experiments Series 2 and 3.
In the experiments for observing the persistence of 9: 10 dimethylbenzan-
thracene one application of 0-5 per cent solution (1000 ,ug.) was made and groups
of 3 mice were killed at appropriate intervals. It was necessary to confine the
exposure to a single application with this concentrated solution owing to its
"caustic effect" on the skin. The skin of any animal which showed obvious
damage was not used for extraction. Histological examination of the skin of
animals treated similarly showed, however, that marked histological changes
occurred during the period of the tests (personal communication from Professor
Orr).
420POLYCYCLIC HYDROCARBONS AND EPIDERMAL CONSTITUENTS
n
II
II
II
I
'1
I.
I
II
II
II
II
II I.I
ji
ii
ii
I I
I
11
I i
I I
n
I I
I I
I I
II
I'
I I
II
I I
r1
I
I
I I
II
!1
3 4 5 6
FIG. 1.-Bound Benzpyrene in 25 mg. dry epidermal protein. (1) Six applications of 0.4
per cent Benzpyrene. (2) Pretreatment of skin with Croton oil. (3) Pretreatment of skin
with Urethane. (4) Pretreatment with Nitrogen mustard. (5) Pretreatment with Corti-
sone. (6) Pretreatment with Maleic anhydride.
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FIG. 2.-Bound hydrocarbon in 25 mg. dry epidermal protein.
Alkaline hydrolysate. Acidified hydrolysate.
(1) 9: 10-dimethyl-1: 2: benzanthracene. (2) Benztetraphene. (3) Perylene.
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FIG. 3.-Persistence of bound D.M.B.A. in 25 mg. dry epidermal protein. One application
of 1000 ,ug. per mouse. (a) Alkaline hydrolysate; (b) Acidified hydrolysate.
Days
FIG. 4.-Persistence of bound 3: 4 benztetraphene in 25 mg. dry epidermal protein. Two applications (total 200 ,Lg.permouse); (a) Alkalinehydrolysate; (b) Acidifiedhydrolysate.
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Four applications of 0-2 ml. of the benztetraphene solution were made during
one hour in order to apply a sufficient amount of hydrocarbon (400,g.) and the
animals killed after 24 hours. For further comparison other groups of mice were
given a single application of0-2 per cent D.M.B. (400,ug.) and killed after 24 hours.
RESULTS.
Fig. 1 sets out the results in the tests ofSeries 1 and gives the amount ofbound
benzpyrene (and/or metabolites) extracted from the alkaline hydrolysate from
samples of dry protein and also the amounts obtained after acidifying the hydro-
lysates. The figures are the average values from duplicate analyses on 25 mg.
samples of alcohol-extracted protein from two separate preparations (4 analyses
in all). The skin from three mice was used for each preparation.
The amounts of bound benztetraphene obtained 24 hours after one application
are similarly shown in Fig. 2, together with the values obtained in the parallel
experiment with 0-2 per cent D M.B.A. The values from a previous test using the
non-carcinogen perylene are also given.
The persistence of bound D.M.B.A. during the first 24 hours after the single
massive application and up to 10 days is shown on Fig. 3 while the persistence of
bound benztetraphene is shown on Fig. 4.
DISCUSSION.
The following observations can be made from the four charts.
1. In Fig. 1 two values appear to differ significantly from the others, namely
the high content ofthe alkaline extract after the nitrogen mustard (+ benzpyrene)
treatment, and the low value for the alkaline extract from the protein ofthe maleic
anhydride treated skins. The latter is low when compared either with the amount
in the companion acidified extract or with respect to the content of the other
alkaline hydrolysates in this series.
2. The amounts recovered from the acidified hydrolysates of the benzpyrene-
treated skin in all the other groups approximated closely to the amount found in
the benzpyrene controles.
3. The bound hydrocarbon in the alkaline hydrolysate from the D.M.B.A.-
treated skins was greater than that obtained with the other hydrocarbons tested
(Fig. 2 and 3).
4. The amount of benztetraphene in extracts from either acid or alkaline
medium was not essentially different from the amount of hydrocarbon in the
analogous B.P. hydrolysates.
5. Significant amounts of bound D.M.B.A. or derivatives were present up to
the 9th or 10th day (Fig. 3). At this time appreciable amounts of" free "fluores-
cent material also remained which could be extracted by warm alcohol. A detailed
quantitative measurement of this was not undertaken as it is recognised that
epidermis not exposed to hydrocarbon yields some "background" fluorescence.
This is, of course, eliminated during the extraction procedures to which the tissues
are subjected before they are finally hydrolysed for the bound fluorescent com-
ponents.
6. Benztetraphene did not persist for so long a period as D.M.B.A. Whether
the elimination of the "acid" component before the disappearance of the
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"alkaline" component (Fig. 4) is of significance is not known. Quite definite
amounts, however, are present 24-48 hours after application and thus we have
another example of a "binding hydrocarbon" in addition to those already
observed.
Any interpretation of the results in Series 1 must be somewhat conjectural.
It is possible that the benzpyrene component from the alkaline extract is a measure
of the combination of the hydrocarbon with damaged tissue. This would account
for the high value after the nitrogen mustard treatment and possibly for that after
the massive dimethyl-benzanthracene treatment. On the other hand it may be
that the enhanced metabolism which accompanies the hyperplasia induced by
nitrogen mustard is associated with increased hydrocarbon oxidation and conse-
quent capacity for protein-hydrocarbon combination. On this view the hyper-
plasia induced by a carcinogen would involve additional complex formation but
this would not necessarily be involved in whatever constitutes carcinogenesis.
The low value after maleic anhydride treatment might be interpreted as resulting
from the reduced activity of tissue enzymes, for this substance is believed to com-
bine with the SH groups of proteins.
Treatment with urethane, described as an effective initiating agent, does not
affect the binding properties of the cell proteins. The results obtained in this
investigation with benztetraphene oppose the hypothesis that skin cancer is the
direct outcome of simple interaction of hydrocarbon and cell protein.
SUMMARY.
1. The amount of benzpyrene bound to epidermal protein of mouse skin has
been determined after application of that carcinogen preceded by treatment
with various agents which induce epidermal changes but which are not in them-
selves carcinogenic.
2. Bound 9: 10 dimethylbenzanthracene has been shown to be present for 10
days after a single massive application of this hydrocarbon.
3. Benztetraphene though non-carcinogenic becomes bound to epidermal
constituents in amounts comniparable to benzpyrene.
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